SOURCE: Telzuit Medical Technologies, Inc.

May 01, 2007 11:00 ET

Telzuit Medical Technologies: Successful Testing of STATPATCH System

ORLANDO, FL -- (MARKET WIRE) -- May 1, 2007 -- Telzuit Medical Technologies, Inc. (OTCBB: TZMT)

--  Successful testing of STATPATCH Wireless Holter
--  Expect to begin shipping product by the end of May 2007
    
Telzuit Medical Technologies, Inc. (OTCBB: TZMT) announced that it has been successful in testing the STATPATCH Wireless Holter System. The final weeks of testing has led to a number of small, "fine-tuning" changes. We believe our product now fully mirrors "wired" holter monitors and EKG devices.

Warren Stowell, CEO of Telzuit, stated that the Company is now ready to make the transition from an R&D phase to being a fully operational company. While we can't predict how quickly the product will be accepted by the market we do believe our product will become a viable alternative in the holter marketplace.

The Company is now building inventory in anticipation of releasing the product, in selected markets, by the end of May 2007.

Telzuit will continue testing in healthy human subjects and make any modifications as appropriate.

About Telzuit Medical Technologies, Inc.

Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine to patients. The STATPATCH System is a full 12-lead, completely wireless Holter monitor. The STATPATCH System has been approved by the FDA under a 510-K filing. Telzuit also provides ultrasound medical imaging services to physicians in Central Florida through six mobile imaging units. Telzuit is based in Orlando. For more information about Telzuit, its business model and its products, please visit the Company's web site: http://www.telzuit.com

Forward-Looking Statements: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.

Contact Information

  • Contact:

    Jerry Balter
    Chief Financial Officer
    Telzuit Medical Technologies, Inc
    407-354-1222